Abstract

Cyclophosphamide (CP) is a well-known chemotherapeutic agent used to treat many gynecological cancers as well as autoimmune disorders such as lupus and rheumatoid arthritis. CP is metabolized in the liver to give two stable toxic compound one of which is Acrolein, a highly electrophilic, α, β-unsaturated aldehyde, which ultimately collects and gets excreted through the bladder. Mesna (sodium-2-mercaptoethane sulfonate) is primarily used to prevent nephrotoxicity by binding to acrolein. Our previous has established that CP, its major metabolite: acrolein and mesna affect female fertility through deterioration of oocyte quality by generation of reactive oxygen species (ROS).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.